Latest University Hospitals Stories
City of Cleveland, University Hospitals, Cleveland Foundation path-breaking model for economic development results in nearly $800 million in annual purchases of goods and services going to local businesses, 5,200 construction jobs, New Project Labor Agreement with Unions, 1,200 permanent jobs, alignment with female and minority-owned businesses. CAMBRIDGE, Mass., May 7, 2013 /PRNewswire/ -- As many urban areas throughout the nation face shrinking populations, growing...
CLEVELAND, Feb. 19, 2013 /PRNewswire/ -- University Hospitals (UH) in Cleveland, Ohio, has received two significant gifts totaling $14.5 million in support of the health system's $1.5 billion Discover the Difference Campaign. Kathleen Coleman has donated $7.5 million to the UH Seidman Cancer Center and Barbara Peterson Ruhlman has made a gift of $6 million to UH MacDonald Women's Hospital, which will be matched by a $1 million gift from the Rainbow Babies & Children's...
GAITHERSBURG, Md., Feb. 13, 2013 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells (product name: LG631-CD34) for bone marrow protection in the treatment of glioblastoma multiforme. Orphan drug designation...
CLEVELAND, Feb. 5, 2013 /PRNewswire/ -- MIT and University of Maryland will convene a national conversation on Feb. 8 about how an innovative business model can help anchor institutions in urban cities to drive economic development and build sustainable community wealth. The panel discussion will be held on Feb. 8 from 2 p.m. to 4 p.m. (EST). Access to live-streaming video: http://bit.ly/Wt6nuB Twitter: #anchorpower A panel of presenters will release a new MIT-University of...
CLEVELAND, Dec. 13, 2012 /PRNewswire/ -- University Hospitals (UH) announced it has achieved its Discover the Difference Campaign goal of $1 billion one year earlier than expected with a $32.5 million gift from the Rainbow Babies & Children's Foundation. As a result, the health system is expanding the fundraising campaign to $1.5 billion - the largest campaign in the history of Northeast Ohio. The Rainbow Foundation, an independent foundation formed in 1887 to advocate for UH...
CLEVELAND, Nov. 26, 2012 /PRNewswire/ -- University Hospitals (UH) and Philips Healthcare are among a group of global leaders in healthcare to showcase the latest medical technology at the new Cleveland Medical Mart & Convention Center. The two organizations will collaborate to highlight innovative imaging technology in use and in development by Philips and other Ohio biomedical companies. Scheduled to open in July 2013, the $465 million Cleveland Medical Mart & Convention...
CLEVELAND, Oct. 31, 2012 /PRNewswire/ -- A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who...
CLEVELAND, Sept. 24, 2012 /PRNewswire/ -- University Hospitals (UH) Case Medical Center is one of five institutions nationwide performing a novel scarless procedure that restores swallowing function in some patients with achalasia, a rare condition where the esophagus is unable to move food into the stomach. Per-oral endoscopic myotomy (POEM) is a state-of-the-art technique to treat patients without any external incisions or outside scars. With POEM, surgeons enter through...
CLEVELAND, Sept. 5, 2012 /PRNewswire/ -- BioMotiv today announced that it has secured $21 million in financing from its founding investors, University Hospitals and the Harrington Family. "BioMotiv is a new model for accelerating breakthrough discoveries into medicines and aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv. "Through their commitment, University Hospitals and the Harrington family...
CLEVELAND, Aug. 21, 2012 /PRNewswire/ -- BioMotiv, LLC, today announced the appointment of Baiju R. Shah as its new chief executive officer, and as a member of its Board of Managers, effective September 1, 2012. Currently, Mr. Shah is president and chief executive officer of BioEnterprise, a business acceleration initiative and partnership among leading Cleveland-area hospitals and health systems. "We are excited that Baiju Shah will be leading BioMotiv, a key part of the...
